Deca-Durabolin 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Usage

1. CONFIRM your full cycle blueprint — including total cycle length, testosterone base dosage, Nandrolone weekly target, and planned PCT date — before opening the vial. Deca-Durabolin's long ester demands front-loaded planning that short-ester compounds do not require.
2. INSPECT the vial visually under good lighting: solution should be clear to pale yellow and free of particulates. Reject the vial if cloudiness or suspended matter is visible and contact your supplier.
3. CALCULATE your draw volume using the 300 mg/ml concentration (e.g., 400 mg dose = 1.33 ml). Warm the vial in your hands for 60 seconds to reduce oil viscosity before drawing.
4. DRAW with an 18–21 gauge needle for efficient aspiration of oil carrier, then swap to a 23–25 gauge, 1–1.5 inch needle for intramuscular administration into the glute, vastus lateralis, or ventroglute site.
5. INJECT slowly (over 20–30 seconds per ml) using Z-track technique to minimise tissue irritation; aspirate briefly prior to injection as a precautionary measure, following your personal harm-reduction protocol.
6. LOG each injection with date, site, and volume drawn. Cross-reference your running total against the 10 ml vial inventory to ensure supply aligns with your planned cycle end date and the two-week pre-PCT cessation window.

Warnings

Frequently asked questions

How do you incorporate Beligas Deca-Durabolin 300mg/ml into a modern bulking cycle?

Deca-Durabolin is positioned as the primary anabolic compound in a modern bulking cycle, run alongside a testosterone base at a ratio of roughly 3:4 (Nandrolone:Testosterone) to maintain hormonal balance. Most practitioners begin both compounds on the same day at week one, aiming for steady-state plasma levels by week 3–4. The 300 mg/ml concentration simplifies weekly dosing mathematics and reduces total injection volume per session.

When in the cycle should you stop taking Nandrolone Decanoate before PCT?

Nandrolone Decanoate should be discontinued approximately two weeks before the final testosterone injection to allow the longer-acting decanoate ester to clear adequately ahead of post-cycle therapy. This staggered cessation strategy — widely referenced in evidence-based harm-reduction literature — prevents residual Nandrolone from blunting HPTA recovery during the early PCT window when SERMs like Nolvadex or Clomid are introduced.

How long does a modern structured Nandrolone Decanoate cycle typically run?

A modern periodised cycle using Nandrolone Decanoate typically spans 12–16 weeks for intermediate users and up to 20 weeks for advanced athletes running planned off-season blocks. The 10 ml vial from Beligas at 300 mg/ml contains 3,000 mg total — sufficient for a full 12-week cycle at 250 mg/week without needing a second vial, which simplifies inventory planning considerably.

Can you draw Beligas Deca-Durabolin 300mg/ml with an insulin syringe for smaller doses?

Standard insulin syringes (0.5 ml or 1 ml, 29–31 gauge) can be used to draw and administer sub-1 ml doses of Deca-Durabolin 300 mg/ml, provided the needle gauge is sufficient to aspirate the oil-based carrier within a reasonable timeframe — warming the vial briefly in the hand reduces viscosity. For weekly doses of 150–300 mg, a 1 ml insulin syringe offers precise measurement and minimises tissue displacement per injection.

How should the Beligas Deca-Durabolin 10ml vial be stored after opening?

After first puncture, store the 10 ml vial at room temperature (15–25°C) away from direct light and moisture; refrigeration is not required and can increase oil viscosity, making drawing harder. Beligas seals vials under nitrogen atmosphere with a multi-layer stopper — provided the stopper is not visibly compromised, in-use stability is maintained across a standard 12–16 week cycle. Discard if the solution appears cloudy or shows visible particulates. (2) angle_used

Manufacturer

Packaging and container integrity are central to Beligas Pharmaceuticals' quality framework for Deca-Durabolin 300mg/ml. Each 10 ml vial is sealed with a coated rubber stopper and aluminium crimp cap — a configuration specifically chosen for multi-dose injectable formats that undergo repeated needle puncture across a 12–16 week cycle. The stopper compound is selected for compatibility with oil-based vehicles and undergoes extractables testing to confirm no leachable contaminants migrate into the solution over the vial's shelf life. Vial glass is Type I borosilicate, the pharmacopoeial standard for parenteral containers requiring resistance to chemical interaction with the enclosed formulation. Crimp integrity and fill volume accuracy are both subject to in-process quality checks at the filling line, with final container closure integrity confirmed before batch release. This packaging discipline ensures that the 3,000 mg of Nandrolone Decanoate inside the vial arrives at the end user in the same verified condition it left the production floor.